IQVIA Q3 2026 Earnings Beat

IQVIA reports 8% revenue growth and 11.3% EPS rise as AI adoption accelerates client wins.

16 cards · 1m 50s · tap to begin

From · · · 1m 50s

IQVIA Q3 2026 Earnings Beat

IQVIA reports 8% revenue growth and 11.3% EPS rise as AI adoption accelerates client wins.

In brief

IQVIA reports 8% revenue growth and 11.3% EPS rise as AI adoption accelerates client wins. IQVIA exceeded earnings guidance with 8% revenue growth, 11.3% EPS increase, and strong AI-driven client wins in Q3 2026. Originally reported by The Motley Fool.

Q3 2026 Results

IQVIA reported third quarter revenue of $4,428 million, 8% growth on reported basis.

Organic Growth Acceleration

Organic revenue growth reached 6%, more than twofold the 2025 Q3 rate.

Constant Currency Growth

Constant currency revenue growth at 8.6% despite foreign exchange fluctuations.

Commercial Solutions Performance

Commercial Solutions revenue grew 6.9% to $1,789 million with strong full-service bookings.

R&D Solutions Growth

R&D Solutions revenue grew 8.7% to $2,639 million with organic growth accelerating.

Adjusted EBITDA Expansion

Adjusted EBITDA grew 8.7% to $1,032 million with 20 basis points margin expansion.

Earnings Per Share

Adjusted diluted EPS rose 11.3% to $3.34, exceeding guidance.

Book-to-Bill Ratio

Book-to-bill ratio at 1.2 reflecting strong full-service outsourcing awards.

R&D Net New Bookings

R&D Solutions net new bookings reached $3.2 billion, 15% year-over-year increase.

Backlog Adjustment

Contracted backlog adjusted to $32.6 billion after $2.1 billion removal of inactive trials.

Emerging Biopharma Funding

Emerging biopharma funding reached $90 billion year to date, up 85% year over year.

AI Agent Deployment

415 AI agents deployed to date, accelerating win rates by two to three points.

Full-Year Guidance

Raised full-year revenue guidance to $17,350 million with 6.3% to 7% growth.

Operational Margin Improvement

80 basis points of margin expansion from operational productivity programs.

Pass-Through Impact

70 basis points headwind from pass-through revenues on gross margins.

Q4 Financial Assumptions

Net interest expense of $210 million and weighted average shares of 169 million.

The bottom line

IQVIA exceeded earnings guidance with 8% revenue growth, 11.3% EPS increase, and strong AI-driven client wins in Q3 2026.

Read the original on The Motley Fool

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on iqvia and related topics.